MO :: Section 6, Chapter 17 (Respite), Subsection 9, – (Case Recording) :: 17.9.1 Composition

MO :: Section 6, Chapter 17 (Respite), Subsection 9, – (Case Recording) :: 17.9.1 Composition

The composition of the Respite Care Provider case file should include the following:

Forms Section (Yellow)

  • Application to Provide Respite Care, CS-RC-1
  • Respite Care Provider Approval, CS-RC-3
  • Foster Respite Care Provider Checklist, CS-RC-2
  • Respite Provider Evaluation/Payment Invoices, CD-111
  • Resource Parent Discipline Agreement, CD119
  • Safe Sleep Practices, CD-117
  • Notification of Hazards, CD-101, if applicable

HIPAA (White)

Correspondence (White)

  • Letters to Respite Provider Family
  • Any other written correspondence (including business e-mail)

Training (Buff)

  • Training record screens (this is only applicable to the Elevated Needs Level B Respite Providers who are required to complete eight (8) hours of Elevated Needs Level B respite training.)

Contracts (Yellow)

  • Cooperative Agreement for the Purchase of Respite Care Services with the Children’s Division, CM-10
  • Cooperative Agreement for the Purchase of Respite Care for Elevated Needs Level B Foster Parents, CM-9

OHI Reports (Pink)

The cover sheet should include:

  • Case Name
  • Date of Report
  • Incident Number
  • Expungement Date

Narrative (Blue)

  • Dictate when a family is awarded or renewed a cooperative agreement for respite care services.
  • Record background screenings were completed
  • Record all home visits and meetings with Respite Resource family
  • Record when training notices for Elevated Needs Level B Respite Providers have been mailed
  • Record when Elevated Needs Level B Resource Provider has participated in training
  • Record any cooperate agreement or qualifications concerns noted and action taken
  • Document closing narrative

Placed Inside and attached to the front flap of the file folder:

  • Placement Report for Foster Home Record, CD104

 

Memoranda History:

CD09-07, CD10-20, CD14-17, CD15-75, CD18-16



Leave a Comment:

Anonymous
The content of this field is kept private and will not be shown publicly.

0 Comments